5 completed, 1 active not recruiting. 5 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 4 | Completed 3, Active not recruiting 1 |
Follow GeoVax, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer COVID-19 Vaccine, Diagnostic Laboratory Biomarker Analysis, Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1 - COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm | Phase 2 | Active not recruiting | GeoVax, Inc. | 63 | 2021-09-27 | 2026-02-11 |
| A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection Placebo Administration, Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 - COVID-19 Infection | Phase 1 / Phase 2 | Completed | GeoVax, Inc. | 119 | 2020-11-19 | 2026-02-10 |
| Combinatorial Therapy to Induce an HIV Remission Combination Intervention - HIV/AIDS | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 11 | 2020-08-01 | 2026-08-28 |
| Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer Ad/PNP, Fludarabine Phosphate - Recurrent Head and Neck Cancer | Phase 1 / Phase 2 | Completed | GeoVax, Inc. | 10 | 2019-02-11 | 2025-03-27 |
| Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults GEO-D03 DNA vaccine, MVA/HIV62B (MVA62B) vaccine, Placebo for GEO-D03 DNA - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 48 | 2012-04-01 | 2021-10-15 |
| A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART JS7 plasmid DNA and MVA62B vaccine - HIV-1 Infection | Phase 1 | Completed | GeoVax, Inc. | 9 | 2010-06-01 | 2017-11-14 |
COVID-19 (2) · Acquired Immunodeficiency Syndrome (1) · Adenoviridae Infections (1) · HIV Infections (1) · Head and Neck Neoplasms (1) · Leukemia (1) · Lymphoma (1) · Multiple Myeloma (1) · Squamous Cell Carcinoma of Head and Neck (1)
COH04S1 COVID-19 vaccine (2) · COVID-19 Vaccines (1) · Vaccines (1) · fludarabine phosphate (1)
United States (6)
A. Dimitrios Colevas, MD (1) · Harriet L Robinson, PhD (1) · Susan Buchbinder (1)
PMID 27711228, PMID 28727817, PMID 41326736
P30CA033572 (2), UM1AI164560 (1)